From bench to bedside – A mission for a healthy life
From bench to bedside – A mission for a healthy life
The DRFZ investigates the long‐term outcomes of rheumatic diseases, including the impact of current treatment options, in order to inform clinical decision making, identify unmet needs and improve health care. Biomedical research identifies the cells initiating and those driving rheumatic diseases, and the underlying molecular mechanisms. Our aim is the development of improved, personalised, at best curative therapies for patients with rheumatic diseases, and their rapid translation into clinical practice.
News
Science at DRFZ
Van Duc Dang: Cell Therapy for CNS Autoimmunity Using Induced Regulatory B Cells Generated with Small Molecules
Denis Poddubnyy: Why a 100% Treatment Response is Rare in Inflammatory Rheumatic Diseases?
Timo Gaber: Mimicking mechanical forces during joint movement in vitro
Jun Dong: Exploring the dynamics of human bone marrow memory T lymphocytes and their impact on immune memory
Mediathek
News | 21.November 2022
Mir-Farzin Mashreghi
...... is the new head of the Systems Rheumatology Research Department
News | 10. March 2022
Anja Strangfeld
... is the head of the Programme Area Epidemiology at the DRFZ
News | 02. November 2022
Carsten Watzl
... has been Chairman of the Scientific Advisory Board of the DRFZ since September 2022